Top

Global Testosterone Replacement Therapy Market 2016-2020

Category : Diagnostic and Biotech  | Published Date : Jul-2016 | Pages : 59
enquire GET DISCOUNT
About Testosterone Replacement Therapy

Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.

Technavio’s analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA

Technavio's report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
• AbbVie
• Allergan
• Eli Lilly and Company
• Endo Pharmaceuticals

Other prominent vendors
• Acerus Pharmaceuticals Corporation
• Antares Pharma
• Bayer HealthCare Pharmaceuticals 
• Bedford Labs
• Clarus Therapeutics
• Ferring Pharmaceuticals
• Forendo Pharma 
• Juniper Pharmaceuticals 
• Lipocine
• MetP Pharma
• Mylan
• Pfizer
• ProStrakan Group 
• Repros Therapeutics
• Sandoz
• TesoRx 
• Teva Pharmaceuticals

Market driver 
• Increase in older population
• For a full, detailed list, view our report 

Market challenge 
• FDA warnings on use of testosterone products
• For a full, detailed list, view our report 

Market trend 
• Entry of SARMs
• For a full, detailed list, view our report 

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.







PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Hypogonadism
• Understanding Hypergonadism
• Pathophysiology
• Symptoms
• Diagnosis
• Treatment
PART 06: Pipeline analysis
• TESTAVAN
• Vibex QST
• LPCN 1021
• REXTORO
• Enclomiphene
• LPCN 1111
• TSX-002
• TEFINA
• THG-1001
• MetP Testosterone Nasal Gel
PART 07: Key buying criteria
PART 08: Market landscape
• Global endocrinology drugs market
• Global testosterone replacement therapy market
• Five forces analysis
PART 09: Market segmentation by dosage form
• Gels
• Injectables
• Patches
• Others
PART 10: Geographical segmentation
• Global testosterone replacement therapy market by geography 2015-2020
• Testosterone replacement therapy market in Americas
• Testosterone replacement therapy market in EMEA
• Testosterone replacement therapy market in APAC
PART 11: Market drivers
• Increase in older population
• High incidence of testosterone deficiency
• Rise in chronic diseases
• Increase in awareness
PART 12: Impact of drivers
PART 13: Market challenges
• Generic erosion
• FDA warnings on use of testosterone products
• Adverse effects
• Physicians are reluctant to prescribe medications with testosterone
• Reluctance to discuss condition
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Entry of SARMs
• Support of patient assistance programs
• Focus on emerging markets
• Application in new therapeutic indications
PART 16: Vendor landscape
• Competitive scenario
• Market analysis 2015
• AbbVie
• Allergan
• Eli Lilly
• Endo International
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Normal levels of testosterone based on gender
Exhibit 03: Normal levels of testosterone at different ages
Exhibit 04: Timeline of testosterone replacement therapy products
Exhibit 05: Advantages and risks associated with use of testosterone products
Exhibit 06: Causes of hypogonadism
Exhibit 07: Symptoms of hypogonadism
Exhibit 08: Diagnostic algorithm of hypogonadism
Exhibit 09: Pipeline portfolio: Global testosterone drugs market
Exhibit 10: Key buying criteria for testosterone replacement therapy
Exhibit 11: Global endocrinology drugs market 2015-2020 ($ billions)
Exhibit 12: Market share of global testosterone replacement therapy market in global endocrinology drugs market
Exhibit 13: Global testosterone replacement therapy market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Global testosterone replacement therapy market by dosage form 2015
Exhibit 16: Segmentation of global testosterone replacement therapy market based on geography 2015
Exhibit 17: Global testosterone replacement therapy market by geography 2015-2020 ($ billions)
Exhibit 18: Global testosterone replacement therapy market by geography 2015-2020
Exhibit 19: Testosterone replacement therapy market in Americas 2015-2020 ($ billions)
Exhibit 20: Percentage share of US in testosterone replacement therapy market 2015
Exhibit 21: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 22: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 23: Global testosterone replacement therapy market: YoY growth and revenue based on geography 2015-2020
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: AbbVie: YoY revenue and growth rate of AndroGel 2013-2015 ($ billions)
Exhibit 27: AbbVie: Key takeaways
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Eli Lilly: YoY revenue and growth rate of Axiron 2013-2015 ($ millions)
Exhibit 30: Geographical segmentation of Axiron by revenue 2015
Exhibit 31: Eli Lilly: Key takeaways
Exhibit 32: Endo International: YoY revenue and growth rate of Fortesta 2013-2015 ($ millions)
Exhibit 33: Endo: Key takeaways
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top